IonQ paced the quantum pure-plays higher on a broad risk-on session, while the industrial-gas chokepoint lagged a rally that favored growth.

IonQ (IONQ) was the strongest liquid name in the basket, up 3.7% to $39.02, without a company-specific catalyst — it rode the day's risk-on bid as long-dated Treasury yields fell and Fed-hike fears eased, the macro backdrop that lifts long-duration compute stories hardest. IonQ sits on the trapped-ion chokepoint: the qubit modality plus the photonic and control stack around it, the part of the quantum stack where a handful of players own the hardware roadmap. On a day the Nasdaq rose 1.4%, the quantum pure-plays behaved like the highest-beta expression of that move.

The laggard was a picks-and-shovels name: Air Products (APD) fell 1.7% to $304.22. Air Products anchors the ultra-high-purity industrial-gas and cryogen chokepoint that feeds both semiconductor fabs and quantum labs — helium, specialty gases, the cold that dilution refrigerators run on. It is a defensive, cash-generative name, and on a session where capital chased growth it was a natural source of funds; Coherent (COHR), the photonics-and-laser supplier, softened alongside it at −1.6% to $264.41.

Breadth across the pure-plays was firmly green. Rigetti (RGTI) added 2.1% to $15.18, D-Wave (QBTS) 2.0% to $16.82, and Quantum Computing Inc. (QUBT) 1.5% to $7.96, while American Superconductor (AMSC) rose 1.8% on the grid-and-superconducting side. The enabling layer was more mixed — Applied Materials −0.6%, MKS −0.7%, Linde −1.1% — a reminder that the semicap and gas suppliers trade on their own cycle even when the qubit names are bid. NVIDIA (+1.8% to $228.45), IBM (+1.3%) and Alphabet (+1.6%) carried the diversified-compute end, keeping the error-correction race in view.

The near calendar is dense. IEEE Quantum Week (QCE26) runs in Toronto September 13–18, the sector's main technical stage. The National Quantum Initiative Reauthorization Act (H.R. 8462 / S. 3597) is targeted for floor votes by roughly the end of September — the policy backbone for federal funding. ASP Isotopes has guided its first commercial silicon-28 shipments for Q3, feeding the isotopically-pure-substrate chokepoint. And in early November the DARPA Quantum Benchmarking Initiative's Stage B concludes and its Stage C downselect window opens — the government's own attempt to separate real machines from roadmaps, and the catalyst most likely to reprice the pure-plays on fundamentals rather than beta.